Certa Dose, Inc. to Showcase "Simple and Brillant" Pediatric Dosing Device at American College of Emergency Physicians 2016 Annual Conference
Certa Dose, Inc. will exhibit the new Certa Dose™ System at the ACEP 2016 Annual Conference and Scientific Meeting on October 16–18, 2016. Medication dosing errors are the #1 medical error in pediatric patients. The Certa Dose System was developed by an Emergency Department physician with the goal of reducing medication dosing errors in pediatrics. Described by emergency personnel as “Simple and Brilliant,” the patented, award winning device will be shown at Booth #S2216.
Las Vegas, NV, October 13, 2016 --(PR.com)-- Certa Dose, Inc. will exhibit the new Certa Dose™ System to conference attendees at the ACEP- American College of Emergency Physicians 2016 Annual Conference and Scientific Meeting to be held October 16–18, 2016. Medication dosing errors are the #1 medical error in pediatric patients. The Certa Dose System was developed by an Emergency Department physician with the goal of reducing medication dosing errors in pediatrics. Described by emergency personnel as “Simple and Brilliant,” the patented, award winning device will be shown at Booth #S2216 in the Exhibit Hall.
“The Certa Dose™ System received an extremely positive response from emergency nurses at last month’s ENA 2016 Annual conference. ACEP16 is a wonderful and timely opportunity to talk with physicians who see first-hand, the need for reducing pediatric dosing errors and we look forward to talking to emergency physicians at this prestigious meeting,” says Ms. Sarah L. Hanssen, President and CEO of Certa Dose, Inc. Caleb Hernandez, DO, FACEP, Certa Dose inventor and Chief Medical Officer, will also be attending the conference and states, “I am particularly interested in meeting and talking with my peers at this conference and obtaining additional insights. We are looking forward to sharing our clinical study results indicating a reduction of critical errors from as much as 37% using today’s standard of care to 0% using Color-Coded Syringes.”
Attendees may stop by booth #S2216 to see the Certa Dose™ System. This innovative system uses the universal pediatric nine color zones first introduced by Broselow-Luten. The first Certa Dose™ products are currently pending regulatory clearance.
About Our Company: Certa Dose, Inc. is a privately owned Delaware C Corporation with operations in Denver, Colorado and Indianapolis, Indiana. Certa Dose, Inc. was founded in 2013 by Dr. Caleb Hernandez to solve the issue of medical dosing errors in pediatrics.
Currently we are working with regulatory authorities to obtain the required clearances to bring the first Certa Dose products to market.
“The Certa Dose™ System received an extremely positive response from emergency nurses at last month’s ENA 2016 Annual conference. ACEP16 is a wonderful and timely opportunity to talk with physicians who see first-hand, the need for reducing pediatric dosing errors and we look forward to talking to emergency physicians at this prestigious meeting,” says Ms. Sarah L. Hanssen, President and CEO of Certa Dose, Inc. Caleb Hernandez, DO, FACEP, Certa Dose inventor and Chief Medical Officer, will also be attending the conference and states, “I am particularly interested in meeting and talking with my peers at this conference and obtaining additional insights. We are looking forward to sharing our clinical study results indicating a reduction of critical errors from as much as 37% using today’s standard of care to 0% using Color-Coded Syringes.”
Attendees may stop by booth #S2216 to see the Certa Dose™ System. This innovative system uses the universal pediatric nine color zones first introduced by Broselow-Luten. The first Certa Dose™ products are currently pending regulatory clearance.
About Our Company: Certa Dose, Inc. is a privately owned Delaware C Corporation with operations in Denver, Colorado and Indianapolis, Indiana. Certa Dose, Inc. was founded in 2013 by Dr. Caleb Hernandez to solve the issue of medical dosing errors in pediatrics.
Currently we are working with regulatory authorities to obtain the required clearances to bring the first Certa Dose products to market.
Contact
Certa Dose, Inc
Sarah L. Hanssen
858-349-5906
www.certadose
info@certadose
Sarah L. Hanssen
858-349-5906
www.certadose
info@certadose
Contact
Categories